1970 related articles for article (PubMed ID: 18375475)
1. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
2. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
Onuigbo MA; Onuigbo NT
Ren Fail; 2008; 30(4):363-71. PubMed ID: 18569908
[TBL] [Abstract][Full Text] [Related]
3. Late onset azotemia from RAAS blockade in CKD patients with normal renal arteries and no precipitating risk factors.
Onuigbo MA; Onuigbo NT
Ren Fail; 2008; 30(1):73-80. PubMed ID: 18197547
[TBL] [Abstract][Full Text] [Related]
4. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study.
Onuigbo MA; Onuigbo NT
Ren Fail; 2008; 30(1):67-72. PubMed ID: 18197546
[TBL] [Abstract][Full Text] [Related]
5. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
Onuigbo MA
Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
[TBL] [Abstract][Full Text] [Related]
6. Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience.
Onuigbo MA; Onuigbo NT
Med Sci Monit; 2005 Oct; 11(10):CR462-9. PubMed ID: 16192897
[TBL] [Abstract][Full Text] [Related]
7. Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients.
Onuigbo MA; Onuigbo NT
Int Urol Nephrol; 2008; 40(1):233-9. PubMed ID: 18196471
[TBL] [Abstract][Full Text] [Related]
8. Untoward effects of chronic dual renin-angiotensin system blockade: influence of previous chronic renal failure.
Robles NR; Cancho B; Barroso S; Martín MV; Sánchez Casado E
Int J Clin Pract; 2006 Sep; 60(9):1035-9. PubMed ID: 16939543
[TBL] [Abstract][Full Text] [Related]
9. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
Onuigbo MA
Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
[TBL] [Abstract][Full Text] [Related]
10. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
11. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.
Onuigbo MA
Ren Fail; 2010; 32(8):954-8. PubMed ID: 20722563
[TBL] [Abstract][Full Text] [Related]
12. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
13. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
Weir MR; Rolfe M
Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
[TBL] [Abstract][Full Text] [Related]
14. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
15. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
16. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
Kiski D; Stepper W; Brand E; Breithardt G; Reinecke H
Nephrol Dial Transplant; 2010 Mar; 25(3):759-64. PubMed ID: 19903660
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
[TBL] [Abstract][Full Text] [Related]
18. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy.
Rocha-Singh KJ; Ahuja RK; Sung CH; Rutherford J
Catheter Cardiovasc Interv; 2002 Oct; 57(2):135-41. PubMed ID: 12357507
[TBL] [Abstract][Full Text] [Related]
19. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
20. Pulse pressure and inhibition of renin-angiotensin system in chronic kidney disease.
Banerjee D; Brincat S; Gregson H; Contreras G; Streather C; Oliveira D; Nelson S
Nephrol Dial Transplant; 2006 Apr; 21(4):975-8. PubMed ID: 16384830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
